SEC Form 4 · accession 0001104659-16-127129
Aralez Pharmaceuticals Inc. · ARLZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth B Lee Jr.
Director
Period of report
Jun 10, 2016
Accepted (ET)
Jun 14, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660719
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par value | Jun 10, 2016 | F | 1,404 | $3.58 | D | 81,952 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This represents shares withheld by the Issuer for payment of withholding tax liability incurred upon the vesting of 9,390 restricted stock units previously granted on June 10, 2015, which vested on June 10, 2016.